Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Geriatrics Reports
Published in: Current Geriatrics Reports 4/2020

01-12-2020 | Insulins | Nutrition, Obesity, and Diabetes (SML Ribeiro, Section Editor)

Traditional Fermented Foods as an Adjuvant Treatment to Diabetes

Authors: Caroliny de Almeida Souza, Ícaro Alves Cavalcante Leite de Oliveira, Victoria Ananias de Oliveira Rolim, Cristina Stewart Bittencourt Bogsan

Published in: Current Geriatrics Reports | Issue 4/2020

Login to get access

Abstract

Purpose of Review

The use of traditional fermented foods as an alternative therapy for diabetes treatment has been widespread used without scientific proof, sometimes aggravating the clinical condition. This work explores the application of fermented foods with anti-glycemic activity for adjuvant therapy which fight against diabetes and differentiates them from those popular fermented foods generally used based on empirical knowledge.

Recent Findings

The role of physiologically active components of foods has changed our understanding of diet effects on human health, placing it in a prominent position, becoming a strategic and alternative treatment for metabolic diseases such as diabetes. However, identifying the use efficacy is somewhat complicated since the diet promotes interference from multiple factors.

Summary

It can be concluded that traditional fermented foods can be considered great helpers in the complementary and alternative treatment of diabetes, improving mechanisms such as glycemic control, recovery or maintenance of body weight, and antioxidant capacity.
Literature
1.
2.
Katz SE. The art of fermentation: an in-depth exploration of essential concepts and processes from around the world. Chelsea Green Publishing, 2012.
3.
El Sheikha AF, Hu DM. Molecular techniques reveal more secrets of fermented foods. Crit Rev Food Sci Nutr. 2020;60(1):11–32.PubMed
4.
Dimidi E, Dashti SR, Rossi M, Whelan K. Fermented foods: definitions and characteristics, impact on the gut microbiota and effects on gastrointestinal health and disease. Nutrients 2019:5:11:8:E1806.
5.
Bogsan CS & Todorov SD. Brazilian kefir: from old to the new world. In: Fermented Foods of Latin America. CRC Press. pp. 98–114. 2017.
6.
Punaro GR, Maciel FR, Rodrigues AM, Rogero MM, Bogsan CSB, Oliveira MN, et al. Kefir administration reduced progression of renal injury in STZ-diabetic rats by lowering oxidative stress. Nitric Oxide. 2014;37:53–60.PubMed
7.
Bezerra AN, Carvalho NS, Viana ACC, Morais SR. Efeito da suplementação de probióticos no diabetes mellitus: Uma revisão sistemática. Revista Hospital Universitário Pedro Ernesto. 2016;15(2):129–39.
8.
•• Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–14 This article is important because it arises from a convention among several specialists to debate and reaffirm the definitions and concepts of probiotics, fermented foods, functional foods, among others. This article is used as a reference to the area.PubMed
9.
Badaró ACL, Guttierres APM, Rezende ACV, Stringheta PC. Alimentos probióticos: aplicações como promotores da saúde humana – parte 1. Nutrir Gerais – Revista Digital de Nutrição. 2008;2(3):1–20.
10.
He J, Zhang F, Han Y. Effect of probiotics on lipid profiles and blood pressure in patients with type 2 diabetes: a meta-analysis of RCTs. Medicine. 2017;96(51):1–7.
11.
Peng T, Wu T, Chao Y. Effect of probiotics on the glucose levels of pregnant women: a meta-analysis of randomized controlled trials. Medicina. 2018;54(5):1–14.
12.
Miani M, Naour JL, Waeckel-Enée E, Chand Verma S, Straube M, Emond P, et al. Gut microbiota-stimulated innate lymphoid cells support b-defensin 14 expression in pancreatic endocrine cells, preventing autoimmune diabetes. Cell Metab. 2018;28(4):557–72.PubMed
13.
Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknows of probiotics. Nat Med. 2019;25:716–29.PubMed
14.
Kerry RG, Patra JK, Gouda S, Park Y, Shin H, Das G. Benefaction of probiotics for human health: a review. J Food Drug Anal. 2018;26(3):927–39.
15.
16.
Hsieh M, Tsai W, Jheng Y, Su S, Wang S, Lin C, et al. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Sci Rep. 2018;8:1–11.
17.
Brazilian Society of Diabetes - SBD, DIRETRIZES DA SOCIEDADE BRASILEIRA DE DIABETES 2019-2020, 2019.
18.
Gross JL, Silveiro SP, Camargo JL, Reichelt AJ, Azevedo MJ. Diabetes Melito: diagnóstico, classificação e avaliação do controle glicêmico. Arq Bra Endocrinol Metabol. 2002;46(1):16–26.
19.
Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, et al. Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.PubMed
20.
21.
22.
Wernimont SA, Sheng JS, Tymkowicz A, Fleener DK, Summers KM, Syrop CH, et al. Adherence to self-glucose monitoring recommendations and perinatal outcomes in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol MFM. 2019;1(3):1–6.
23.
Trevisan DD, São-João T, Cornélio M, Jannuzzi F, de Sousa MR, Rodrigues R, et al. Effect of an ‘implementation intention’ intervention on adherence to oral anti-diabetic medication in Brazilians with type 2 diabetes. Patient Education and Counseling. 2019. DisponÍvel em. https://​doi.​org/​10.​1016/​j.​pec.​2019.​10.​003.
24.
Assunção TS, Ursine PGS. Estudo de fatores associados à adesão ao tratamento não farmacológico em portadores de diabetes mellitus assistidos pelo Programa Saúde da Família, Ventosa, Belo Horizonte. Ciência & Saúde Coletiva. 2008;13:2189–97.
25.
26.
Simon-Tuval T, Shmueli A, Harman-Boehm I. Adherence to self-care behaviors among patients with type 2 diabetes—the role of risk preferences. Value Health. 2016;19(6):844–51.PubMed
27.
Thomas JJ, Moring JC, Harvey T, Hobbs T, Lindt A. Risk of type 2 diabetes: health care provider perceptions of prevention adherence. Appl Nurs Res. 2016;32:1–6.PubMedPubMedCentral
28.
29.
Cevik AB, Akinci AC, Baglama SS. The use of complementary and alternative medicine among lymphoma and cancer patients with a solid tumor: oncology clinics at northern and southern Turkey. Complement Ther Med. 2019;47:1–8.
30.
Organização para a Alimentação e Agricultura das Nações Unidas - FAO. (2012). Internationally coordinated action for the promotion of tea consumption. Committee On Commodity Problems - Intergovernmental Group On Tea, 22th Session. Colombo, Sri Lanka.
31.
Luz MT. Cultura contemporânea e medicinas alternativas: novos paradigmas em saúde no fim do século XX. PHYSIS: Revista de Saúde Coletiva. 2005;15:145–76.
32.
Raposo VL. Complementary and alternative medicine, medical liability 4 and the proper standard of care. Complement Ther Clin Pract. 2019;35:183–8.PubMed
33.
Leal F, Schwartsmann G, Lucas HS. Medicina complementar e alternativa: uma prática comum entre os pacientes com câncer. Revista da Associação Médica Brasileira. 2008;54(6):471–86.
34.
Cevik AB, Akinci AC, Baglama SS. The use of complementary and alternative medicine among lymphoma and cancer patients with a solid tumor: oncology clinics at northern and southern Turkey. Complement Ther Med. 2019;47:1–8.
35.
Neto JFR, Faria AA, Figueiredo MFS. Medicina complementar e alternativa: utilização pela comunidade de Montes Claros, Minas Gerais. Revista da Associação Médica Brasileira. 2009;55(3):296–301.PubMed
36.
Zezos P, Nguyen GC. Use of complementary and alternative medicine in inflammatory bowel disease around the world. Gastroenterol Clin N Am. 2017;46(4):679–88.
37.
Hollander JM, Mechanick JI. Complementary and alternative medicine and the management of the metabolic syndrome. J Am Diet Assoc. 2008;108(3):495–509.PubMed
38.
Nystrand BT, Olsen SO. Consumers’ attitudes and intentions toward consuming functional foods in Norway. Food Qual Prefer. 2020;80:1.
39.
Bogue, J., Collins, O., & Troy, A. J. Market analysis and concept development of functional foods. In D. Bagchi & S. Nair (Eds.), Developing new functional food and nutraceutical products 2017:29–45.
40.
Hilton J. Growth patterns and emerging opportunities in nutraceutical and functional food categories: market overview. In D. Bagchi & S. Nair (Eds.), Developing new functional food and nutraceutical products 2017:1–28.
41.
Thamer KG, Penna ALB. Caracterização de bebidas lácteas funcionais fermentadas por probióticos e acrescidas de prebiótico. Cienc Tecnol Aliment. 2006;26(3):589–95.
42.
Kabir, Y. Functional foods in cancer prevention and therapy. Academic Press, ISBN 0128165383, 9780128165386; 2020:522.
43.
Quintero-Angel M, Mendoza DM, Quintero-Angel D. The cultural transmission of food habits, identity, and social cohesion: a case study in the rural zone of Cali-Colombia. Appetite. 2019;139:75–83.PubMed
44.
Ramli AM, Zahari MSM, Halim NA, Aris MHM. The knowledge of food heritage identithy in Klang Valley, Malaysia. Procedia Soc Behav Sci. 2016;222:518–27.
45.
Tanwar M, Tanwar B, Tanwar RS, Kumar V, Goyal A. Himachali dham: food, culture, and heritage. J Ethnic Food. 2018;5(2):99–104.
46.
Ronchetti AG, Müller SG. Revista Memorare 2016:3:3: 37–53.
47.
Marco ML, Heeney D, Binda S, Cifelli CJ, Cotter PD, Foligné B, et al. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol. 2017;44:94–102.PubMed
48.
49.
Rai AK, Pandey A, Sahoo D. Biotechnological potential of yeasts in functional food industry. Trends Food Sci Technol. 2019;83:129–37.
50.
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–14.PubMed
51.
52.
Raizel R, Santini E, Kopper AM, Filho ADR. Efeitos do consumo de probióticos, prebióticos e simbióticos para o organismo humano. Revista Ciência & Saúde. 2011;4(2):66–74.
53.
Bogsan, C.S.; Nero, L.A.; Todorov, S.D. From traditional knowledge to an innovative approach for bio-preservation in food by using lactic acid bacteria. In: Beneficial Microorganisms in Food and Nutraceuticals. Springer, Cham. 2015:1–36.
54.
Sartorelli DS, Franco LJ. Tendências do diabetes mellitus no Brasil: o papel da transição nutricional. Caderno de Saúde Pública. 2003;19(1):29–36.
55.
• Bourrie BCT, Cotter PD, Willing BP. Traditional kefir reduces weight gain and improves plasma and liver lipid profiles more successfully than a commercial equivalent in a mouse model of obesity. J Funct Foods. 2018;46:29–37 This article shows that kefir is able to counter the effects of a high-fat diet and to modulate lipid metabolic responses in the body, such as cholesterol control. However, this effect was observed only in the traditional kefir and not in the industrialized one, probably due to microbiological differences and biochemical profile.
56.
Gao J, Ding G, Li Q, Gong L, Huang J, Sang Y. Tibet kefir milk decreases fat deposition by regulating the gut microbiota and gene expression of Lpl and Angptl4 in high fat diet-fed rats. Food Res Int. 2019;121:278–87.PubMed
57.
• Zubaidah E, Afgani CA, Kalsum U, Srianta I, Blanc PJ. Comparison of in vivo antidiabetes activity of snake fruit Kombucha, black tea Kombucha and metformin. Biocatal Agric Biotechnol. 2019;17:465–9 This article is important because it assesses the use of kombucha in comparison to a reference medication for the treatment and control of diabetes. In addition to reducing risk factors, it was observed that the use of kombucha had effects similar to the drug of choice and that this effect was not present in unfermented tea.
58.
Punaro GR, Maciel FR, Rodrigues AM, Rogero MM, Bogsan CSB, Oliveira MN, et al. Kefir administration reduced progression of renal injury in STZ-diabetic rats by lowering oxidative stress. Nitric Oxide. 2014;37:53–60.PubMed
59.
Srihari T, Karthikesan K, Ashokkumar N, Satyanarayana U. Antihyperglycaemic efficacy of kombucha in streptozotocin-induced rats. J Funct Foods 2013. 2013;5(4):1794–802.
60.
•• Anal AK. Quality ingredients and safety concerns for traditional fermented foods and beverages from Asia: a review. Fermentation. 2019;5:8. https://​doi.​org/​10.​3390/​fermentation5010​008This article deals with the stability and microbiological safety of traditional fermented foods, since the fermentation process is capable of adding several benefits to food matrices, such as increased digestibility and inactivation of toxins. In addition, this article discusses the safety of traditional fermented foods at an industrial level, a very relevant topic in the area.CrossRef
61.
Yang Z, Zhou F, Ji B, Li B, Luo Y, Yang L, et al. Symbiosis between microorganisms from kombucha and kefir: potential significance to the enhancement of kombucha function. Appl Biochem Biotechnol. 2008;160(2):446–55.PubMed
62.
Marsh A, Sullivan O, Hill C, Ross R, Cotter P. Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples. Food Microbiol. 2014;38:171–8.PubMed
63.
McGee H. On food and cooking: the science and lore of the kitchen. New York, Scribner. 2011:433–41.
64.
Nascimento ML. Doseamento de cafeína e análise sensorial de chá preto (Camellia sinensis) preparado com diferentes condições de extração. In: Dissertação (Mestrado) - Universidade Nova de Lisboa. Programa de: Pós-Graduação em Ciências Gastronómicas da Faculdade de Ciências e Tecnologia; 2014.
65.
• Yin X, Chen Y, Lu W, Jin T, LI L. Association of dietary patterns with the newly diagnosed diabetes mellitus and central obesity: a community based cross-sectional study. Nutr Diabetes. 2020;10:16. https://​doi.​org/​10.​1038/​s41387-020-0120-yThis article is also of high importance, as it assessed the diet impact on risk factors associated with diabetes. This study looked at a considerable group of human patients (1432) in China, a hotspot region focused on the consumption of traditional fermented foods in the world.CrossRefPubMedPubMedCentral
66.
67.
Ramalingam S, Ramasamy SM, Vasu G, Gopalarishnan R. Antihyperglycemic potential of black tea extract attenuates tricarboxylic acid cycle enzymes by modulating carbohydrate metabolic enzymes in streptozotocin-induced diabetic rats. Indian J Clin Biochem. 2020;35(3):322–30.PubMed
68.
Dashti MH, Morshedi A. Chronic consumption of kombucha and black tea prevents weight loss in diabetic rats. Iran J Diabetes Obes. 2010;2(2):23–6.
69.
Bhattacharya S, Gachui R, Sil PC. Effect of kombucha, a fermented black tea in attenuating oxidative stress mediated tissue damage in alloxan induced diabetic rats. Food Chem Toxicol. 2013;60:328–40.PubMed
70.
Adade EE. Anti-diabetic and probiotic effect of kombucha on alloxan-induced diabetic rats. Univ Ghana Coll Basic Appl Sci. 2019;99.
71.
Aloulou A, Hamden K, Elloumi D, Ali MB, Hargafi K, Jaouadi B, et al. Hypoglycemic and antilipidemic properties of kombucha tea in alloxan-induced diabetic rats. BMC Complement Altern Med. 2012;12:63–71.PubMedPubMedCentral
72.
Argilés, J.M.; Campos, N.; Lopez-Pedrosa, J.; Rueda, R.; Rodriguez-Mañas, L. Skeletal muscle regulate metabolism via interorgan crosstalk: roles in health and disease 2016:17:9:789–796.
73.
Alsayadi M, Jawfi YA, Belarbi M, Soualem-Mami Z, Merzouk H, Sari DC, et al. Evaluation of anti-hyperglycemic and anti-hyperlipidemic activities of water kefir as probiotic on streptozotocin-induced diabetic Wistar rats. J Diabetes Mellitus. 2014;4(2):85–95.
74.
Maciel FR, Punaro GR, Rodrigues AM, Bogsan CSB, Rogero MM, Oliveira MN, et al. Immunomodulation and nitric oxide restoration by a probiotic and its activity in gut and peritoneal macrophages in diabetic rats. Clin Nutr. 2016;35(5):1066–72.PubMed
75.
Ostadrahimi A, Taghizadeh A, Mobasseri M, Farrin N, Payahoo L, Gheshlaghi ZB, et al. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Iran J Public Health. 2015;44(2):228–37.PubMedPubMedCentral
76.
Sagoo MK, Gnudi L. Diabetic nephropathy: is there a role for oxidative stress. Free Radic Biol Med. 2018;116:50–63.PubMed
77.
Judiono DR, Hadisaputro S. Biomolecular aspects of plain kefir antidiabetic potentials. Int J Food Nutr Publ Health. 2012;5(1/2):7–23.
78.
Judiono J, Hadisaputro S, Indranila KS, Cahyono B, Suzery M, Widiastuti Y, et al. Effects of clear kefir on biomolecular aspects of glycemic status of type 2 diabetes mellitus (T2DM) patients in Bandung, West Java [study on human blood glucose, c peptide and insulin]. Funct Food Health Dis. 2014;4(8):340–8.
79.
Pereira C, Lourenço F, Castro P, Rola J, Jacquet J. A Diabetes Mellitus e suas complicações. Relembrar para prevenir. Med Int. 1999;6(1):54–66.
80.
Teruya K, Yamashita M, Tominaga R, Nagira T, Shim SY, Katakura Y, et al. Fermented milk, kefram-kefir enhances glucose uptake into insulin-responsive muscle cells. Cytotechnology. 2002;40:107–16.PubMedPubMedCentral
Metadata
Title
Traditional Fermented Foods as an Adjuvant Treatment to Diabetes
Authors
Caroliny de Almeida Souza
Ícaro Alves Cavalcante Leite de Oliveira
Victoria Ananias de Oliveira Rolim
Cristina Stewart Bittencourt Bogsan
Publication date
01-12-2020
Publisher
Springer US
Keywords
Insulins
Insulins
Published in
Current Geriatrics Reports / Issue 4/2020
Electronic ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-020-00337-3

Other articles of this Issue 4/2020

Current Geriatrics Reports 4/2020 Go to the issue

Nutrition, Obesity, and Diabetes (SML Ribeiro, Section Editor)

Type 2 Diabetes and Mediterranean Diet in Older Adults: a Brief Review of the Evidence

Invited Commentary

Xerosis Cutis in the Aging Population: an Approach to Diagnosis and Treatment

Dermatology and Wound Care (C Sayed, Section Editor)

Cellulitis Mimics in the Geriatric Patient

Nutrition, Obesity, and Diabetes (SML Ribeiro, Section Editor)

Diabetes, microRNA, and Nutrition in Geriatrics

Dermatology and Wound Care (C Sayed, Section Editor)

Melanoma Diagnosis and Treatment in the Elderly

Obesity and Diabetes (SML Ribeiro, Section Editor)

Dietary Patterns, Diabetes, and Aging
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits